← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #465 OF 1,000 MOST-CITED

Physical plant - clean and sanitary

FDA cited this observation 41 times across 37 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods41
BY FISCAL YEAR
FY20267
FY20258
FY20245
FY20231
FY20223
FY20211
FY20201
FY20196
FY20185
FY20174

How FDA worded it — real examples

You did not maintain your physical plant in a clean and sanitary condition and in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

T. E. Neesby Inc · Friant, California · Foods · 2026-05-21

You did not maintain your physical plant in a clean and sanitary condition and in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

Bxter Services, LLC · Fort Mohave, Arizona · Foods · 2026-05-14

You did not maintain your physical plant in a clean and sanitary condition.

Pure Solutions, Inc. · Tampa, Florida · Foods · 2026-01-30

You did not maintain your physical plant in a clean and sanitary condition.

Redrose Manufacturing Ltd · Houghton Le Spring · Foods · 2026-01-29

You did not maintain your physical plant in a clean and sanitary condition and in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

First America Nutrition LLC · Orange Park, Florida · Foods · 2025-12-10

You did not maintain your physical plant in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

Purever Nutrition Inc · Richmond · Foods · 2025-11-18

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Contamination controlFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →